← All Sponsors
SPONSOR

Circle Pharma

Total Trials
1
Recruiting
1
Phases
Phase 1

Circle Pharma is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer.

The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Circle Pharma

How many clinical trials has Circle Pharma sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Circle Pharma, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Circle Pharma research focus on?
Circle Pharma clinical trials span Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer, Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Circle Pharma clinical trial?
To participate in a Circle Pharma trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Circle Pharma trials with current recruitment status updated daily.

Clinical Trials by Circle Pharma

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology